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Abstract. Platelet-derived growth factor (PDGF) stim- 
ulates fibroblasts to move over collagen and contract 
three-dimensional collagen gels, processes important in 
wound repair and fibrocontractive diseases. These pro- 
cesses depend on a2131 integrin ligation of collagen and 
PDGF induces the expression of this integrin. Several 
lines of evidence presented here suggest that PKC-~ 
plays a role in ~2 integrin gene expression. The induc- 
tion was blocked by chemical inhibitors for protein ty- 
rosine kinases (PTK), genistein, and protein kinase C 
(PKC), chelerythrine, and bisindolylmaleimide GF 
109203X. Cells depleted of phorbol 12-myristate 13- 
acetate (PMA)-inducible PKCs by chronic treatment 
with PMA still demonstrated an a2 response to PDGF 
indicating that a non-PMA-sensitive PKC isoform was 
required. PDGF induced kinase activity in PKC-~ im- 
munoprecipitates. Antisense oligonucleotides comple- 
mentary to 5' end of PKC-~ mRNA sequences blocked 
the PDGF-induced increase of a2 mRNA levels up to 
70%, indicating PKC-~, a non-PMA-sensitive PKC iso- 
form, is a component of the PDGF stimulatory pathway 
for o~  2 mRNA synthesis. A 961-base pair (bp) upstream 
region of a2 gene/CAT construct transfected into hu- 
man dermal fibroblasts was positively regulated by 
PDGF as judged by CAT enzymatic levels. Both PTK 
and PKC inhibitors blocked PDGF-stimulation of the 
o~2 promoter fragment/CAT construct, indicating that 
the phosphorylation requirement occurred at a2 pro- 
moter-directed transcription level. Therefore, we pro- 
pose that PDGF-stimulatory pathway of c~2 integrin 
gene expression involves multiple cellular protein ki- 
nases, one of which is PKC-~. 
C 
ELL adhesion and migration are important elements 
in such physiological processes as wound healing, 
inflammation,  differentiation  and  development, 
and in the pathobiology of tumor invasion. The integrin 
superfamily plays a major role in the mediation of adhe- 
sive interaction between cells and extracellular matrices. 
Integrins are heterodimers composed of an a  chain and a 
[3 chain. [31 integrin can form a complex with at least ten 
different c~ subunits, namely O~I~OL  9 and av (Haas and Plow, 
1994; Hynes, 1992). Among them, az[31 integrin is known 
to mediate cell adhesion to and migration on type I col- 
lagen (for review see Santoro and Zutter, 1995 and refer- 
ences therein). In the late phase of wound healing, tissue 
contraction also probably requires the az[31 integrin based 
on previous in vitro experiments (Schiro et al., 1991). The 
cellular level of integrins in part determines the adhesive 
behavior of cells and is subject to modulation by growth 
and differentiation factors. The regulatory stimuli for c~  2 
integrin subunit expression include platelet-derived growth 
factor (PDGF) 1 (Ahlen and Rubins, 1994; Xu and Clark, 
1996),  transforming  growth  factor-J3  (Riikonen  et  al., 
1995), epidermal growth factor (Fujii et al.,  1995), and its 
ligand, collagen (Klein et al., 1991; Xu and Clark, 1996). 
PDGF elicits a  wide range  of physiological responses 
such as development, wound healing, inflammation, and 
oncogenesis. The mitogenic effect of PDGF is mediated 
through receptors that possess an intrinsic tyrosine kinase 
activity (for review see Claesson-Welsh, 1994). Binding of 
PDGF to its cell surface receptor causes receptor dimer- 
ization and phosphorylation of substrates including the re- 
ceptor itself and other intracellular proteins that associate 
with  the  tyrosine-phosphorylated receptors.  Those  pro- 
teins include enzymes that generate active second messen- 
ger  molecules  such  as  phospholipase  C%  phosphatidyl- 
inositol  3'-kinase,  protein  kinases  (Src  and  Raf)  and 
phosphatases (PTP-1D), and adaptor proteins such as Shc 
that are thought to link activated receptors to the Ras sig- 
naling pathway. The biochemical properties of these effec- 
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of association with and phosphorylation by the receptor. 
Thus, PDGF triggers a diverse array of downstream early 
signaling events. 
One cellular response to PDGF stimulation is gene in- 
duction. PDGF responsive genes include immediate early 
genes such as egr-1 (Mundschau et al., 1994), c-fos (Green- 
berg and  Ziff,  1984),  and c-jun  (Rauscher  et  al.,  1988), 
slow immediate genes such as c-myc (Kelly et al., 1983) and 
chemokine gene MCP-1 (JE/MCP-1) (Freter et al., 1995), 
and late genes such as stromelysin (Diaz-Meco et al., 1991) 
and interstitial collagenase (Circolo et al., 1991). However, 
the events linking early second messenger activation by 
PDGF with subsequent gene expression are unclear. 
One such candidate is protein kinase C (PKC). A family 
of serine/threonine-specific protein kinases, PKC has been 
linked to cell proliferation, differentiation, and regulation 
of gene expression. This enzyme family can be divided into 
three groups (Nishizuka, 1995). The classic group contain- 
ing isoforms c~, 131, 1311, and ~/depends on  Ca 2+ and phor- 
bol ester/diacylglycerol (DAG) for activity. The nonclassic 
group containing isoforms 8, e, xl, ~, and Ix is phorbol es- 
ter/DAG-dependent but does not require Ca  2÷. An atypi- 
cal group containing PKC-h, r, and ~ is not activated by 
phorbol ester/DAG. PKC has been associated with vari- 
ous PDGF-stimulated cellular activities such  as  Na+/H ÷ 
exchange  in  normal  murine  mammary  gland  epithelial 
(NMuMG) and Chinese hamster ovary (CHO) cells (Ma 
et  al.,  1994)  and  C3H  10T1/2  (Schwartz  and  Lechene, 
1992); formation of prostaglandins in NIH 3T3 fibroblasts 
(Finkenzeller et al.,  1993); proliferation of human mesan- 
gial cells (Choudhury et al., 1993), proliferation of vascular 
smooth muscle cells (VSMC) from spontaneously hyper- 
tensive rats (SHR) (Inui et al., 1994); translocation of 80-kD 
MARCKS  in  Swiss  3T3  cells  (Herget  and  Rozengurt, 
1994);  downregulation of a  major PKC substrate  80-kD/ 
MARCKS in Swiss  3T3 fibroblasts (Brooks et al., 1992); 
transcription  of vascular endothelial growth  factor gene 
(VEGF) in NIH 3T3 fibroblasts (Finkenzeller et al., 1992); 
and slow immediate genes JE/MCP-1 (Freter et al., 1995) 
and late gene stromelysin (Sanz et al., 1994) in NIH 3T3 fi- 
broblasts. 
The mechanism by which  PDGF regulates ~2  integrin 
gene expression has become a  focus of our research.  In 
this  report, chemical inhibitors were  used  to investigate 
the involvement of both protein tyrosine kinases and pro- 
tein kinase C in PDGF regulation of c~2 integrin gene ex- 
pression.  Furthermore,  human  dermal  fibroblasts  were 
transfected with et  2 promoter region/CAT constructs to es- 
tablish  the  link  between  PDGF-induced  kinase  activity 
and  ct  2 promoter-directed gene  transcription. Data  from 
the studies indicated the involvement of an atypical PKC. 
Therefore, antisense oligonucleotides were used to deter- 
mine that PKC-~ activation was required for PDGF stimu- 
lation of ct  2 gene expression. 
Materials and Methods 
Cell Culture and Reagents 
Human dermal fibroblast cultures were established by outgrowth from 
healthy human skin biopsies (kindly provided by Marcia Simon, Depart- 
ment of Dermatology, SUNY at Stony Brook). The cells were maintained 
in DMEM (GIBCO BRL, Gaithersburg, MD), supplemented with 10% 
FCS (Atlanta Biologicals, Norcross, GA), 100 U/ml penicillin, 100 U/ml 
streptomycin (GIBCO BRL), and grown in a  humidified atmosphere of 
5%  CO2 and 95%  air at 37°C.  Cells between population doubling levels 
(PDL)  15 and 20 (the 6th and 10th passage) were used for the experi- 
ments. In experiments where inhibitors were used, levels of lactate dehy- 
drogenase activity measured (Sigma LD Diagnostic kit) were similar re- 
gardless  of  cells  that  were  cultured  in  the  presence  or  absence  of 
inhibitors. Plasmids pa2961-CAT and cytomegalovirus-CAT (CMV-CAT) 
have been  described  previously (Zutter  et  al.,  1994).  Plasmid  RSVq3- 
galactosidase was kindly provided  by Lorne Taichman, Department of 
Oral Biology and Pathology (SUNY at Stony Brook). PDGF-BB was gen- 
erously provided by Charles Hart of ZymoGenetics (Seattle, WA). Hu- 
man c~  2 and a 3 cDNA probes were  generously provided  by Yoshikazu 
Takada of The Scripps Institute (San Diego, CA) (Takada and Hemler, 
1989; Takada et al., 1991).  as eDNA was purchased from GIBCO BRL. 
Genistein was obtained from Sigma Chem. Co. (St.  Louis, MO).  Bisin- 
dolylmaleimide GF 109203X was purchased from CalBiochem (La Jolla, 
CA). Chelerythrine was purchased from LC laboratories (Woburn, MA). 
Polyclonal antibodies against human protein kinase C-{ and -/~ were pur- 
chased from GIBCO BRL and Santa Cruz Biotechnology (CA), respec- 
tively. Monoclonal antibody against 13-tubulin was purchased from Chemi- 
con  (Temecula,  CA).  Phosphatidylserine  was  purchased  from  Sigma 
Chem Co. [14C]Chloramphenical, [a-~zP]dCTP, and [y-~2p]ATP were ob- 
tained from Du Pont New England Nuclear (Boston, MA). 
RNA Blot Analysis of Total Cellular RNA 
Total  RNA  was  isolated  using  a  guanidinium  thiocyanate  method 
(Chromczynski and Sacchi, 1987). For Northern blot hybridization, 3-5 ~xg 
of total RNA was treated with glyoxal/DMSO, separated by electrophore- 
sis on a  1%  agarose gel in 10 mM phosphate buffer, pH 7.0,  and trans- 
ferred  to  Hybond  +  nylon  membranes  (Amersham  Corp.,  Arlington 
Heights, IL).  Ethidium bromide (0.5  p~g/ml) was included in the gel to 
monitor equal loading by the quantity of 18S  and 28S ribosomal RNA 
present,  eDNA  probes  were  labeled  with  [a-32p]dCTP  by  the random 
primer  procedure  (Du  Pont  New  England  Nuclear).  Oligonucleotide 
probes  were  end-labeled  with  [~-32P]ATP  and  polynucleotide  kinase 
(Boehringer Mannheim, Indianapolis, IN). The filters were hybridized to 
the labeled probes in QuickHyb solution (Stratagene, La Jolla, CA) for 3 h 
at 68°C and washed according to manufacturer's protocol. After autora- 
diography (Kodak X-Omat AR) at -80°C for optimal exposure, signal in- 
tensity was determined by densitometry. Values shown are representative 
of at least two independent experiments. An oligonucleotide complemen- 
tary to 28S  ribosomal RNA was used as an additional control of equal 
loading (Clontech, Palo Alto, CA). 
DNA Transfection 
Adult human dermal fibroblasts were passaged at 5-7 ×  105 per 10-cm 
plate. Transfection was performed 22-24 h after passage. P[asmid DNA 
(15 ~g per plate) and pRSV-13gal  control DNA (15 ~g per plate) in 1 ml 
0.25 M CaCI2 were added dropwise to 1 ml 2 ×  HEBS (50 mM Hepes, pH 
7.05,  280 mM NaCl,  1.5  mM Na2HPO4)  to form a  precipitate.  Cells in 
plates were rinsed twice with DMEM. Precipitate was added to the plate 
and incubated for 20 rain at 37°C in 5%  CO2.  DMEM containing 10% 
FBS and 50 mM chloroquine was added to 10 ml. After 4 h, medium was 
replaced with 0.5% FBS. After 32 h, PDGF-BB or PMA were added at 30 
and 50 ng/ml, respectively, and further incubated for 15 h. Protein extracts 
were prepared and CAT enzyme activity was analyzed according to pub- 
lished protocols (Bignon et al, 1993; Lopata et al., 1984). 
Downregulation of PKC-~ Protein by Antisense 
Inhibition of Translation 
Phosphorothioate DNA oligonucleotides with the sequences 5'-ATGC- 
CCAGCAGGACC-3' (sense 1143), 5'-GGTCCTYGCTGGGCAT-3' (anti- 
sense 1142)and 5'-GGTCCTGCTPGGGCATGCGAAAGC-3' (antisense 
1144)  were synthesized by Promega (Madison, WI). Subconfluent adult 
human dermal fibroblasts were treated with oligonucleotides in DMEM 
containing 20 i~g/ml DOTMA/DOPE (lipofectin, GIBCO BRL) for 6-8 h 
at 37°C in the presence of 5% CO2. After this time the medium containing 
DOTMA was replaced by fresh medium containing appropriate oligonu- 
cleotides. After 48 h, the medium was replaced with fresh medium con- 
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cubation for  18 h, total  RNA was isolated and analyzed with Northern 
blotting and hybridization. 
Immunoprecipitation  and In Vitro PKC-~ 
Activity Assay 
Human dermal fibroblasts treated in the presence or absence of oligonu- 
cleotides were  cultured with or without PDGF-BB  for  16-24 h. The in 
vitro PKC-~ kinase assay was performed according to  modification of a 
previously described procedure (Lozano et al., 1994).  Briefly, cell extracts 
were prepared in the lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% 
Triton X-100, 2 mM EDTA, 1 mM EGTA, and proteinase inhibitors) and 
incubated at 4°C overnight with a  polyclonal anti-PKC-~ antibody. The 
immune complexes were  recovered  by  anti-rabbit  lgG  agarose  beads 
(Sigma). The resulting immunoprecipitates were  washed three  times in 
cold with a buffer containing 35 mM Tris, pH 7.5,  15 mM MgCI2,  1 mM 
MnCI2, 0.5 mM EGTA, 25 ~g/ml teupeptin, and 25 izg/ml aprotinin before 
mixed in a final volume of 50 v~l in assay mixture (35 mM Tris, pH 7.5,  15 
mM MgCI2,  1 mM MnClz, 0.5 mM EGTA, 0.1 mM CaC12, 1 mM sodium 
orthovanadate, 1 mg/ml histone llI-ss (Sigma), and 100  t-~M ['¥-3zP]ATP 
with or without 280 ~g/ml phosphatidylserine) and incubated at 30°C for 
10 min. After reactions were stopped by the addition of 100 mM EDTA 
and 2 mM ATP, 1/5 vol of the supernatant was spotted onto phosphocellu- 
lose p81  papers (Whatman, Clifton, N J)  and subsequently washed with 
1% phosphoric acid six times. 32p incorporation was quantitated using a 
scintillation counter. In some experiments the remaining supernatant was 
analyzed by SDS-PAGE followed by autoradiography. 
Immunoblotting 
Human dermal fibroblasts in the presence or the absence of oligonucle- 
otides were cultured with or without 30 ng/ml PDGF-BB for 16-24 h. Cell 
extracts were prepared in the lysis buffer (50 mM Tris, pH 7.5,  150 mM 
NaC1,  1% Triton X-100, 2 mM EDTA, 1 mM EGTA, and proteinase in- 
hibitors).  5  p,g protein-containing cell  extracts  were  separated  on  8% 
SDS-polyacrylamide gels and transferred to polyvinylidene fluoride mem- 
branes (Immobilon P; Millipore, Bedford, MA). The membranes were in- 
cubated with a blocking solution containing 1% BSA, 2% horse serum, 50 
mM Tris, pH 7.5,150 mM NaCI, and 0.05% Tween 20 for 1 h, and then in- 
cubated overnight at 4°C with polyclonal antibodies against PKC-~ at 4 
ixg/ml  or PKC-p. at  1  i~g/ml.  After incubation with  horseradish peroxi- 
dase-conjugated goat anti-rabbit  antibody  (1:1,000  dilution; Amersham 
Corp., Arlington Heights, IL) in 50 mM Tris, pH 7.5,  150 mM NaCl, and 
0.05% Tween 20 for 1 h at room temperature, the blots were then visual- 
ized with enhanced chemiluminescence (ECL; Amersham). Protein load- 
ing was controlled  by blotting  the  same membrane with  a  monoclonal 
anti-13-tubulin at 1:1,000 dilution. 
Results 
PDGF-BB and PMA Induce ~2 mRNA Levels and 
Promoter-directed Gene Transcription 
Previous studies have shown that PDGF-BB induces a~ in- 
tegrin  mRNA  steady-state  levels  in  human  foreskin 
(Ahlen and Rubins, 1994) and adult dermal (Xu and Clark, 
1996)  fibroblasts.  The time course here showed that this 
induction occurs as early as 4 h after PDGF was added and 
peaked at 24 h (Fig.  1 A). PMA, a tumor promoter activat- 
ing protein kinase C, also induced a2 mRNA steady-state 
levels, but the steady-state levels peaked earlier than that 
by PDGF (Fig. 1 B). Maximal induction was observed at 8 h 
and dropped significantly by 24 h. 
To determine that increased ~2 mRNA steady-state lev- 
els occurred at least in part as a consequence of transcrip- 
tion,  transient  expression  assays were  performed.  Previ- 
ously, it has been found that a region between 92 and 961 
base pairs  upstream of the transcription  start  site  of hu- 
man el2 gene consists of numerous consensus enhancer ele- 
Figure 1.  Time course of integrin ~2 subunit mRNA steady-state 
level induced by PDGF and PMA. Normal human dermal fibro- 
blasts were cultured 1 d in 10% FCS/DMEM followed by 3 d in 
1% FCS/DMEM. Such cultures were then stimulated by (A) 30 
ng/ml PDGF-BB  or (B)  50 ng/ml PMA and  incubated  for the 
time indicated. Total RNA was probed  with human c~  2 integrin 
cDNA. Equal loading was monitored by UV light examination of 
ethidium bromide stained gel and confirmed by hybridization of 
the same blot with 3ep-labeled probe for 28S ribosomal RNA. 
ments  (Zutter  et  al.,  1994)  including  those  PDGF-  or 
PMA-responsive sequences, i.e., SIFE (sis-inducible factor 
binding  element;  Wagner et  al.,  1990),  SRE  (serum  re- 
sponsive element; Treisman, 1985; Rupprecht et al., 1993), 
AP-1  (Angel  et  al.,  1987),  and  NF-KB-(Hansen  et  al., 
1992) binding sites. Therefore for these assays, two a2 pro- 
moter-CAT  constructs,  pa292-CAT  and  pet2961-CAT, 
were  transfected  into  adult  human  dermal  fibroblasts 
which were then subjected to serum deprivation for 48 h 
followed by stimulation with  PDGF and PMA for 16 h, 
separately or together. Cell lysates were assayed for CAT 
activity (Fig. 2). In multiple experiments, the pa2961-CAT 
was induced by both PDGF and  PMA (Fig.  2), whereas 
the pa292-CAT was not (data not shown). This result was 
consistent  with  transcriptional  regulation  directed  by  a 
PDGF- and PMA-inducible a2 promoter. 
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A CAT construct, pa2961-CAT which contains 961 base pairs of 
a2 upstream region, was transfected into normal human dermal 
fibroblasts.  Cotransfection with RSV-[3-galactosidase  was used as 
an internal control. Transfected cells were starved for 48 h before 
treatment with PDGF and PMA for 16 h, separately or together, 
and cellular proteins were extracted. After normalization with 
[~-galactosidase activity,  CAT enzymatic activity  was determined 
by thin layer chromatography. After autoradiography, the levels 
of acetylated chloramphenicol were quantified by clipping the ra- 
dioactive spots from the TLC plates and by counting them in a 
liquid  scintillation  counter.  The  graphic  results  shown  are  the 
mean  value  -+SD of three  independent  experiments.  Relative 
CAT activity is defined as the fold-increase of CAT activity gen- 
erated  from cells  treated with  various additatives  compared to 
cells without treament. 
The PDGF Induction of a2 lntegrin Expression 
Requires Protein Phosphorylation by Both Protein 
Tyrosine Kinase and Protein Kinase C 
The  signaling  cascades  from PDGF  receptor  stimulation 
to increased a2 gene transcription  have not been defined. 
Since the PDGF receptor is a protein tyrosine kinase,  the 
involvement  of  tyrosine  phosphorylation  in  the  PDGF 
stimulation of ct2 mRNA was examined with a tyrosine ki- 
nase  inhibitor,  genistein  (Akiyama  and  Ogawara,  1991). 
Fig.  3  A  demonstrates  that  treatment  of fibroblasts  with 
genistein  at  100  IxM  blocked  PDGF  stimulation  of  a: 
mRNA.  PMA,  a  well  known protein  kinase  C  activator, 
was expectedly not antagonized by genistein. 
The  PDGF  receptor,  a  tyrosine  kinase,  generates  dia- 
cylglycerol upon activation which, like PMA, is theoreti- 
cally a potent inducer of classic and nonclassic protein ki- 
nase  C. Therefore,  it was of interest  to evaluate  whether 
protein kinase  C  was required  for PDGF induction  of a2 
mRNA.  Two  specific  protein  kinase  C  inhibitors  were 
used,  chelerythrine  (Herbert  et  al.,  1990)  and  bisindolyl- 
maleimide  GF 109203X (BIM; Toullec et al.,  1991).  BIM 
inhibited  both  PDGF and  PMA induction  whereas  chel- 
erythrine  had  no  effects  on  PMA  induction  and  incom- 
pletely  inhibited  PDGF  induction  (Fig.  3  B).  Therefore, 
protein kinase C is also involved in PDGF pathway for c~  2 
mRNA induction. 
The PDGF Induction of  Ol  2 Transcription Requires Both 
Protein Tyrosine Kinase and Protein Kinase C 
To substantiate that protein phosphorylation is required for 
ae integrin gene expression, transient expression assay with 
a pa2961-CAT construct was performed in the presence or 
absence of PKC or PTK inhibitors.  After transfection, hu- 
man dermal fibroblasts were starved for 48 h  followed by 
stimulation  with  PDGF and  PMA in the presence or ab- 
sence of BIM, chelerythrine, or genistein. Cell lysates were 
assayed for CAT activity. PDGF-induced promoter activ- 
ity was completely inhibited by genistein or BIM, but only 
partially by chelerythrine (Fig. 4 A). Unlike PDGF, PMA 
induced  the  promoter  activity  even  in  the  presence  of 
genistein  or chelerythrine  but not BIM  (Fig. 4  B). These 
results  demonstrate  that  there  is  a  consistency in  the  re- 
quirement of PKC and tYFK activities between the promoter 
directed gene expression and the mRNA steady-state level 
(Fig. 3, A  and B). Therefore, the phosphorylation require- 
ment  occurs  at  the  level  of promoter-directed  transcrip- 
tion of a2 gene. 
The PDGF Induction of a2 Expression Requires a 
Non-PMA-inducible Protein Kinase C 
Although both PDGF and PMA use  protein  kinase  C  to 
induce a2 expression,  there were disparities  between  two 
activation pathways. The time course and the sensitivity to 
chelerythrine  differed  between  two  stimuli.  In  addition, 
PDGF induction of c~  2 mRNA expression required protein 
synthesis while PMA stimulated expression did not (Fig. 5). 
Thus, we decided to examine  whether  the  two activators 
actually  use  the  same  isoforms  of  protein  kinase  C.  A 
widely used strategy is to deplete cellular PMA-inducible 
PKC levels by treating cell culture chronically with PMA 
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and  PMA  stimulation  of cx  2 
mRNA  level.  Cells  were 
treated  with  inhibitors  for 
protein  tyrosine  kinase  and 
protein kinase C  for 2 h  be- 
fore  addition  of  30  ng/ml 
PDGF  and  50  ng/ml  PMA. 
Total RNA was probed with 
human  c~  2  integrin  cDNA. 
Equal loading was monitored 
by UV  light examination of 
ethidium bromide stained gel 
and confirmed by hybridiza- 
tion  of  the  same  blot  with 
32p-labeled  probe for 28S  ri- 
bosomal  RNA.  (A)  Protein 
tyrosine kinase inhibitor, 100 
t~M  genistein (GS)  and  (B) 
protein kinase C inhibitors, 5 
p~M bisindolylmaleimide GF 
109203X  (BIM)  and  1  p.M 
chelerythrine (CT). 
(Larrodera et al., 1990).  This approach depletes PKC iso- 
forms  sensitive  to  DAG/PMA  activation.  Thus,  we  ex- 
posed  quiescent  human  fibroblast cultures  to  PMA  (300 
ng/ml)  for 48  h.  ~2  mRNA  steady-state levels were  then 
determined  following  the  addition  of  either  PDGF  or 
PMA. Although PMA was unable to induce c~  2 mRNA  in 
cells  after  PMA-inducible  PKC  depletion,  PDGF  pro- 
moted  a  potent  response  which was  even higher  than  in 
cells  not  pretreated  with  PMA  (Fig.  6).  These  results 
strongly suggest that, although PMA is capable of activat- 
ing c~  2 mRNA,  PDGF  uses  an  atypical PKC  isoform not 
activated by PMA. 
Xu et al. Integrin Regulation by PDGF  L  305 Figure 4.  Inhibition  of PDGF stimula- 
tion of ~2 promoter activity. Fibroblasts 
were  cotransfected  with  pa2961-CAT 
and  RSV-13-galactosidase  and  46  h 
later treated with PTK and PKC inhib- 
itors for 2  h  before stimulation  with 
(A) 30 ng/ml PDGF and (B) 50 ng/ml 
PMA for 16 h. CAT activity was deter- 
mined after normalization with 13-galac- 
tosidase activity. The transfection  with 
cytomegalovirus-CAT  (CMV)  which 
contains strong viral promoter was per- 
formed in parallel. The assay shown is 
representative of three similar experi- 
ments.  The  graphic  quantification  is 
the  mean value  of three independent 
assays  ---SD. GS,  100  ixM  genistein; 
BIM,  5  ixM  bisindolylmaleimide  GF 
109203X; CT, 1 ~M chelerythrine. 
PDGF Induces Activation of  PKC-~ 
One of the atypical PKC isoforms, ~, has been proposed in 
PDGF  signal  transduction  by both  direct  and  indirect 
evidence.  Dominant  kinase-defective mutants  of PKC-~ 
impair PDGF activation of stromelysin gene promoter di- 
rected  transcription  in  NIH-3T3 fibroblasts  (Sanz  et  al., 
1994).  Products  of several PDGF-inducible  enzymes are 
PKC-~ activators, such as phosphatidylinositol 3,4,5-triphos- 
phate  (PIP3), phosphotidic acid,  and phosphatidylcholine 
hydrolysis products (Nakanishi et al., 1993; Dominguez et al., 
1992).  The involvement of PKC-~ in PDGF-induced ~2 in- 
tegrin expression was therefore considered as a possibility. 
To assess direct correlation between PDGF and PKC-~ ac- 
tivation, the PDGF-stimulated PKC-~ kinase activity was 
assayed in vitro with fibroblast extracts. Human dermal fi- 
broblasts were treated with PDGF in the presence or ab- 
sence of BIM. PKC-~ present in the cell extracts was im- 
munoprecipitated  with  a  polyclonal  antibody.  Hinstone 
III-ss was phosphorylated  by kinase  activities associated 
with the  immunoprecipitates. PDGF increased PKC-~ ki- 
nase activity (Fig. 7 and Table I). The presence of BIM, a 
specific PKC inhibitor, reduced the PDGF-induced PKC-~ 
activity to almost basal levels. Phosphatidylserine, a PKC 
activator,  induced  the  kinase  activity  similar  to  PDGF. 
Therefore, PKC-[ appears to become activated, as deter- 
mined by kinase activity associated with PKC-~ immuno- 
precipitates, in response to stimulation with PDGF in hu- 
man fibroblasts. 
PKC-( Downregulation by Antisense Oligonucleotides 
Inhibits PDGF Induction of a2 Expression 
The  correlation  between  PKC  activation  and  PDGF  in- 
duction of a2 mRNA as revealed by PKC inhibitors pre- 
sented  convincing  circumstantial  evidence  for  PKC  in- 
volvement in PDGF signal transduction  pathway leading 
to et  2 expression. Given that PMA-inducible PKCs had no 
effect on the  pathway, it suggests the  involvement of an 
atypical isoform. To test this possibility, a more specific in- 
hibitor of these PKC isoforms was sought. One approach 
is to deplete  a  specific PKC subtype through  translation 
inhibition by antisense oligonucleotides. 
Antisense  phosphorothioate  oligonucleotides,  comple- 
mentary to the 5'-end of the PKC-[ messenger starting at 
the translation initiation codon (Barbee et al., 1993),  were 
synthesized  and  added  to  the  medium  of  human  fibro- 
blasts to a concentration of 2.5-4.0 IxM. We chose an anti- 
sense target sequence located at the beginning of the open 
reading frame of PKC-~ cDNA because this GC-rich site is 
in a  nonconserved variable region of PKC family (V1 re- 
gion;  Nishizuka,  1992)  which  allows  the  design  of a  se- 
quence effectively unique to PKC-~ when compared with 
cDNA sequences of other PKCs. Furthermore, this RNA 
site has been effectively targeted by antisense oligonucle- 
otides  in  murine  T  lymphocytes  (Gomez  et  al.,  1995). 
"Sense" oligonucleotides were used as control. The deple- 
tion  of PKC-~  protein  levels  by  antisense  inhibition  of 
translation was monitored by kinase activity of PKC-~ im- 
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stimulation of et  2 mRNA level.  Cells  were treated with protein 
synthesis inhibitor cycloheximide (CHX) at 7.5 ~g/ml for 15 min 
before addition  of 30 ng/ml PDGF and  50 ng/ml PMA.  Total 
RNA was probed with human ere integrin cDNA. Equal loading 
was  monitored by UV light  examination  of ethidium  bromide 
stained gel and confirmed by hybridization of the same blot with 
32P-labeled probe for 28S ribosomal RNA. 
Figure 6.  Stimulation of a2 mRNA levels by PDGF and PMA af- 
ter chronic treatment of fibroblasts with PMA. Quiescent human 
dermal fibroblasts either untreated, or treated with BIM for 2 h, 
or chronically incubated (48 h with PMA [300 ng/ml]) were stim- 
ulated with PDGF (30 ng/ml) or PMA (50 ng/ml) for 16 h. Total 
RNA was probed with human ct  2 integrin cDNA. Equal loading 
was monitored  by UV light  examination  of ethidium  bromide 
stained gel and confirmed by hybridization of the same blot with 
32p-labeled probe for 28S ribosomal RNA. 
munoprecipitates  (Fig. 8 A) and by Western blotting (Fig. 
8 B) with antibody specific for human PKC-~. Incubation 
of subconfluent human dermal fibroblasts for 48 h  in me- 
dium containing antisense  oligonucleotides, but not sense 
oligonucleotides, significantly downregulated PKC-~ asso- 
ciated  kinase  activity  and  protein  level  in  a  dose-depen- 
dent manner  (Fig.  8, A  and B). The possibility that  such 
antisense  inhibition  may  be  random  downregulation  of 
cellular  proteins  was  examined  by  reprobing  the  mem- 
brane  with  another  PKC isotype,  p,  (Fig.  8  B).  The  un- 
changed  amount  of cellular  PKC-~  even  at  the  maximal 
dose of antisense oligonucleotides used (4 ~M) confirmed 
the specificity of the antisense inhibition of PKC-~. In ad- 
dition, total PKC enzymatic activity was not substantially 
altered  by antisense  oligonucleotides  to PKC-~  (data  not 
shown).  Such cells  were  treated  with  PDGF for 16-24 h 
and harvested for analysis of a2 mRNA expression.  Anti- 
sense  treatment  inhibited  PDGF induction  of a2 expres- 
sion up to 70%  (Fig. 9, A  and B), consistent with the re- 
suits obtained when the two PKC inhibitors, chelerythrine 
and  BIM, were  used  (Fig.  3  B).  Therefore,  PKC-~  is  in- 
volved in PDGF induction of the c~2 integrin subunit.  Pre- 
viously, we have found that PDGF increased a5 and a3 in- 
tegrin  mRNA  levels  (Xu  and  Clark,  1996).  To  examine 
whether  PKC-~ is required  for et2 specifically or for inte- 
grin mRNAs in general, the same RNA blot was reprobed 
for et  5 and  c~3. Interestingly,  the  antisense  treatment  also 
downregulated  another  PDGF-induced  integrin  messen- 
ger RNA, as, but not or3, indicating that PKC-~ activity is 
required for PDGF-induced mRNA levels of selective in- 
tegrins. 
Discussion 
We report here that PDGF and PMA induced a2 integrin 
mRNA  level  through  promoter-directed  transcription. 
By using  inhibitors  for PTK  and  PKC,  we  further  show 
that this PDGF activation  requires  both kinase  activities. 
Xu et al. lntegrin Regulation by PDGF  1307 Figure 7.  Increased phosphorylating activity in immunoprecipi- 
rates of PKC-~ from PDGF-stimulated human dermal fibroblasts. 
Subconfluent  normal human dermal fibroblasts  were either un- 
treated or stimulated  for 18 h with 30 ng/ml PDGF-BB in the 
presence or absence  of 5 ixM BIM. Cell extracts were prepared 
and PKC-~ was immunoprecipitated in the absence or presence 
of competing peptide.  Kinase reactions  were performed for 10 
min at 30°C either in the absence or presence of 280  ixg/ml of 
phosphatidylserine  (PS) as described  in Materials  and Methods. 
Histon III-ss (Sigma) phosphorylation was determined by autora- 
diography following separation of proteins by 10% SDS-PAGE. 
The film was exposed for 1.5 h. Quantitation was determined by 
liquid scintillation counting of each aliquot as shown in Table I. 
Furthermore, specific depletion of PKC-~ proteins by an- 
tisense  oligonucleotide-mediated  translational  inhibition 
blocked  PDGF  induction  of the  same  gene,  as  did  the 
chemical inhibitors of PKC. 
Many investigators have shown that PDGF signal trans- 
duction pathways use protein tyrosine phosphorylation as 
their first step of activation with two exceptions, the imme- 
diate  early  genes,  c-fos  and  egr-1  (Lee  and  Donoghue, 
1991;  Mundschau  and  Failer,  1995;  Mundschau  et  al., 
1994).  PKC and mitogen-activated protein (MAP) kinase 
are often effectors of PDGF pathways that have direct im- 
pact on gene transcription.  PKC is involved in PDGF in- 
duced expression of the slow immediate genes JE/MCP-1 
and vascular endothelial growth factor (VEGF)  (Finken- 
Table I. PDGF-induced Increase of PKC-( Activity 
Conditions  Counts per minute 
Control  1,568 +  188 
PDGF  6,490 ±  653 
PDGF +  BIM  1,850 -  347 
PDGF +  peptide  665 ±  102 
Control  +  PS  4,821  ±  1,301 
Cell lysates from fibroblasts  untreated or treated with PDGI  z for 18 h were immuno- 
precipitated  with polyclonal  antibody  against  PKC-~ in the presence  or absence of a 
synthetic peptide the antibody was raised against. The immunoprecipitates  were incu- 
bated with histone llI-ss for 10 min at 30°C in kinase assay buffer. Unless specified, 
the reactions  were carried out in the absence  of phosphatidylserine  (PS). The kinase 
activity was determined  by measuring  the incorporation  of 32p from [~-32p]ATP into 
histone III-ss as described  in Materials  and Methods.  The results represent  the mean 
-+ SD of three independent experiments.  One of the experiments  was shown as Fig. 7. 
zeller et al., 1992),  and stromelysin, a late responding gene 
(Sanz et al., 1994). 
In the case of c~2 gene activation, the fact that PKC-~, in- 
stead  of  PMA-sensitive  PKC  isoforms,  is  required  for 
PDGF  gene  induction  in  human  skin  fibroblasts  is  pre- 
ceded by similar observations in PDGF-induced stromel- 
ysin expression in NIH 3T3 fibroblasts (Sanz et al., 1994). 
In addition, sphingomyelinase and tumor necrosis factor 
(TNFc0-induced nuclear factor (NF)-KB-dependent pro- 
moter activation  (Lozano et  al.,  1994),  IL-2-mediated T 
cell proliferation (Gomez et al., 1995),  PDGF-induced mi- 
togenic  responses  in  swiss  3T3  cells  and  insulin-induced 
maturation of Xenopus oocytes (Berra et al., 1993) are all 
PKC-~-dependent processes. 
Although  it is not well understood,  PKC-~, an atypical 
PKC  isoform that  does  not  have  diacylglycerol  (DAG) 
and phorbol ester binding domain, is reportedly activated 
by  phosphatidylinositol  3,4,5-triphosphate  (PIP3),  phos- 
photidic acid, and hydrolysis of phosphatidylcholine, prod- 
ucts of PDGF-inducible enzymes (Dominguez et al., 1992; 
Homma et al., 1993; Larrodera et al., 1990; Ma et al., 1994; 
Nakanishi et al., 1993; Nakanishi and Exton, 1992).  PIP3 is 
generated by phosphatidylinositol 3-kinase (PI3K) activa- 
tion  (Auger  et  al.,  1989;  Valius  and  Kazlauskas,  1993); 
phosphatidic acid is generated by phospholipase D  (PLD) 
(Lee et al., 1994);  and phosphatidylcholine (PC) is hydro- 
lyzed by phospholipase C  (PLC) (Dominguez et al., 1992, 
Homma et  al.,  1993;  Larrodera  et  al.,  1990;  Ma  et  al., 
1994).  Thus,  there  is  increasing  evidence  that  PKC-~  is 
part of important pathway(s) in PDGF signaling. Activa- 
tion of PI3K, PLD, and several types of PLCs is dependent 
on  protein  tyrosine  phosphorylation  (Chen  et  al.,  1994; 
Homma et al., 1993;  Lee et al., 1994;  Rodriguez-Viciana 
et al.,  1994).  The  data presented here that  inhibitors  for 
PKC, as well as PTK, interfered PDGF signaling pathway 
toward a2 expression is consistent with these observations. 
Transfection of human  fibroblasts  with  a  pa2961-CAT 
construct  demonstrated  that  this  PDGF-induced  second 
messenger pathway has a direct link to transcriptional acti- 
vation of the ~2 gene (Fig. 4). How might the activation of 
PKC-~  lead  to  ot  2 gene  transcription?  Although  down- 
stream targets of PKC-~ are  yet to  be completely eluci- 
dated,  possibilities  include  direct  or  indirect  control  of 
transcription  factors.  PKC-~ has  been  shown to  regulate 
NF-KB  activity  through  its  ability  to  phosphorylate  the 
NF-KB  inhibitor protein,  IKB (Diaz-Meco et al.,  1994b). 
Therefore activation of PKC-~ can lead to NF-KB released 
from its  inhibitor  protein  and  subsequently  translocated 
into nucleus where it would activate a group of genes that 
have appropriate responsive elements.  Another  observa- 
tion that is of interest is the nuclear presence of PKC-~ in 
rat brain (Hagiwara et al., 1990)  and human dermal fibro- 
blasts  (data  not  shown).  Recently,  two  other  PKC  iso- 
forms, 8 and ~, were also found present in nuclei isolated 
from rat cardiac myocytes (Ventura et al., 1995). Although 
its biochemical significance has yet to be determined, the 
nuclear  location of PKC-~ suggests it may directly phos- 
phorylate  transcription  factors  in  nuclei.  Alternatively, 
PKC-~ may indirectly regulate transcription factors. Phor- 
bol  ester-activated  PKC  phosphorylates  and  activates 
Raf-1, which in turn activates MAPK through a protein ki- 
nase cascade (Kolch et  al.,  1993;  Marquardt  et al.,  1994; 
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PKC-~ activity and protein levels by anti- 
sense inhibition of translation. Subconflu- 
ent normal dermal human fibroblasts were 
either  untreated  or  treated  with  sense 
(1143)  or  antisense  (1142)  oligonucle- 
otides at different concentration in DMEM 
containing 20  ~g/ml DOTMA for 6-8 h. 
After  this  time  the  medium  containing 
DOTMA was replaced by fresh medium 
containing  appropriate  oligonucleotides 
which were replaced 48  h  later by fresh 
oligonucleotides before  stimulation  with 
30  ng/ml  PDGF for  18  h.  Total cellular 
proteins were  extracted,  quantified  with 
BCA assay and assayed for PKC-~ in vitro 
kinase  activity or  protein  level.  (A)  In 
vitro  kinase  activity  in  immunoprecipi- 
tates of PKC-~. The kinase activity was de- 
termined by measuring the incorporation 
of 32p from [~/-32p]ATP into histone III-ss 
as  described  in  Materials  and  Methods. 
(B) Western blot detection of PKC-g and 
PKC-~  in  total  cell  extracts.  Detection 
with  a  monoclonal  antibody  against 
13-tubulin was used as a control for protein 
loading. 
Sozeri et al., 1992), Substrates of mitogenic-activated pro- 
tein kinase  (MAPK) include several transcription factors 
such as Jun and Fos. PKC-~ also can activate MAPK through 
a  different mechanism.  It is associated with and activates 
MAPK kinase (MEK) and MAPK complex in vitro (Diaz- 
Meco et al., 1994a). Raf protein, however, is not associated 
with or phosphorylated by PKC-~ (Diaz-Meco et al., 1994b). 
The first 961  base pairs (bp) of the a2 promoter region 
consist of many regulatory elements including NF-KB and 
AP-l-binding sequences (Zutter et al., 1994).  This is con- 
sistent with PKC-~'s ability to generate NF-KB and AP-1- 
binding activity. In addition, there have been reports that 
new  PDGF  responsive  elements  are  located  in  both  the 
slow immediate gene JE/MCP-1 and the late gene stromel- 
ysin (Freter et al., 1995; Sanz et al., 1994). The nuclear fac- 
tor binding to the PDGF responsive element of JE/MCP-1 
gene is a serine/threonine phosphoprotein and nuclear ex- 
tracts from cells overexpressing PKC-~ give DNA binding 
to the PDGF responsive element of stromelysin gene com- 
parative to that induced by PDGF. It is thus possible that 
undefined DNA regulatory elements might be responsible 
for the phosphorylation-regulated a 2 gene expression. De- 
tailed mapping of a2 promoter regulatory sequences in re- 
sponse to PDGF is currently under way. 
Dermal  fibroblasts  appear  to  use  this  PDGF  second 
messenger pathway to induce a  gene set that includes c~  2 
integrin subunit, stromelysin-1 (Sanz et al., 1994) and me- 
talloproteinase-1 (MMP-1; data not shown). The proteins 
translated from these genes are essential for fibroblast in- 
teraction with interstitial collagen matrices. 
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